The global nicotinic acid market size was valued at USD 331.15 million in 2024 and is anticipated to grow from USD 338.24 million in 2025 to reach USD 400.67 million by 2033, growing at a CAGR of 2.14% during the forecast period (2025–2033). The growth of the market is attributed to rising prevalence of cardiovascular diseases.
One of the major drivers of the global nicotinic acid market is the rising demand for dietary supplements and nutraceuticals. With increasing awareness about preventive healthcare, consumers are turning to vitamins and functional ingredients like nicotinic acid (Vitamin B3) for improved metabolic, neurological, and skin health. This compound is widely used in multivitamin supplements and energy products, driven by the growing popularity of wellness-focused lifestyles.
According to the Council for Responsible Nutrition, over 75% of U.S. adults used dietary supplements in 2023, indicating strong market potential. Additionally, the pharmaceutical industry continues to utilize this compound in therapies for niacin deficiency and lipid disorders. Innovations such as extended-release formulations have improved patient tolerance, thereby enhancing adoption. The convergence of health-conscious behavior, aging populations, and product innovation is significantly contributing to the sustained growth of the global market.
The use of nicotinic acid in animal feed is gaining momentum due to its essential role in metabolic functions and overall animal health. It is widely incorporated into poultry and livestock diets to improve growth rates, reproductive performance, and feed efficiency.
These findings highlight this compound’s potential in improving poultry resilience and productivity under heat stress conditions. With climate change increasing the frequency of heatwaves, livestock producers are increasingly turning to nutritional interventions like niacin to maintain productivity and animal welfare in challenging environments.
To get more insights about this report Download Free Sample Report
The surging incidence of cardiovascular diseases globally is a significant driver for the global market. Nicotinic acid, also known as niacin, is clinically proven to reduce LDL (bad cholesterol), triglycerides, and increase HDL (good cholesterol), making it a crucial component in lipid-modifying therapy.
With rising lifestyle-related diseases, sedentary habits, and poor dietary patterns, the demand for cholesterol-lowering agents like niacin is expected to grow, especially in prescription drugs and dietary supplements for cardiovascular health management.
Despite its therapeutic benefits, nicotinic acid (niacin) is often associated with side effects that can limit its widespread use. One of the most common issues is skin flushing, which can be uncomfortable and discourages continued use. At higher doses, this compound has been linked to liver toxicity, gastrointestinal disturbances, and insulin resistance, especially in patients with pre-existing conditions.
These adverse reactions often result in poor patient compliance and hesitation among healthcare providers to recommend it as a long-term solution. Additionally, the availability of alternative cholesterol-lowering drugs with fewer side effects further restricts the market growth.
Governments in emerging economies are increasingly mandating food fortification to address micronutrient deficiencies, creating a strong opportunity for industry producers.
These regulations elevate B3 demand in both public distribution and private markets. With rising disposable incomes and consumer awareness, fortified food and supplement sales are surging. This regulatory momentum in India and similar initiatives emerging across Asia and Africa offer a timely, scalable growth path for nicotinic acid suppliers targeting food, feed, and nutritional sectors.
The market in North America is witnessing steady growth due to increasing health consciousness and rising adoption of preventive healthcare supplements. The region’s advanced pharmaceutical sector is integrating nicotinic acid in lipid-modifying therapies to address high cholesterol levels. Additionally, robust investment in nutraceutical R&D and growing demand for fortified foods and beverages are fueling market expansion. Regulatory support for vitamin enrichment in processed foods and widespread use of this compound in animal nutrition to enhance livestock productivity also contribute significantly to the market's regional development.
The Asia Pacific region is experiencing rapid growth in the market due to increasing consumer awareness of vitamin deficiencies and rising disposable incomes. The booming pharmaceutical and nutraceutical industries are incorporating niacin in supplements and cholesterol-lowering medications. Growing urbanization and lifestyle-related diseases are driving demand for fortified food and beverages. Additionally, the livestock sector is increasingly utilizing this compound to boost animal health and productivity, supported by government efforts to enhance food safety and nutritional quality through animal feed additives.
Europe’s market is growing steadily, driven by stringent regulations promoting food fortification and preventive healthcare practices. The region’s strong emphasis on clean-label and functional food products supports the use of vitamins like this compound in cereals, beverages, and snacks. Demand is further boosted by the aging population and rising awareness of cardiovascular health. Additionally, the animal feed industry increasingly adopts this compound to support metabolic efficiency and growth in livestock, aligning with regional goals of improving food security and sustainable farming practices.
The natural segment holds a dominant share in the global market owing to rising consumer preference for clean-label and plant-based ingredients. Increasing demand for naturally sourced vitamins in dietary supplements and fortified foods is driving this growth. Consumers associate natural sources with better bioavailability and fewer side effects, which enhances market appeal. Regulatory support for natural additives in food and pharma applications is also bolstering the segment's dominance across both developed and emerging markets.
The dry form segment leads the global market owing to its extended shelf life, ease of transportation, and cost-effectiveness in bulk handling. This form is preferred in pharmaceutical formulations, animal feed additives, and dietary supplements for its high stability and compatibility with other dry ingredients. Manufacturers also favour the dry form due to its low production cost and versatility in blending. These advantages contribute significantly to its widespread adoption across various end-use industries.
Animal feed represents the dominant application segment in the market, driven by its critical role in improving animal metabolism and productivity. Nicotinic acid enhances feed efficiency, supports energy utilization, and prevents nutritional deficiencies in livestock. Rising meat and dairy consumption worldwide has led to increased demand for fortified animal feed, particularly in the poultry and swine sectors. Furthermore, growing awareness about livestock health and quality output continues to support this segment's robust market position.
Online retail is gaining significant traction in the market due to increasing digital penetration and consumer inclination toward e-commerce. The convenience of home delivery, product variety, and competitive pricing are major factors boosting online sales. Consumers, especially those purchasing dietary supplements and wellness products, prefer online platforms for better accessibility and information. Moreover, the growing presence of health-focused e-commerce platforms and direct-to-consumer brands is extending the reach of nicotinic acid-based products globally.
Companies in the global market are focusing on expanding production capacities, enhancing purity levels, and investing in R&D to develop advanced formulations with reduced side effects. Many are forming strategic partnerships and entering emerging markets to tap into growing demand from nutraceutical, pharmaceutical, and animal nutrition sectors. Additionally, efforts are being made to comply with stringent regulatory standards and promote vitamin-fortified products to cater to health-conscious consumers.
Jubilant Life Sciences Limited
Jubilant Life Sciences Limited, now operating as Jubilant Pharmova Limited, is a key player in the global market, known for being one of the world’s largest manufacturers of Vitamin B3 (nicotinic acid and niacinamide). Headquartered in India, the company serves the pharmaceutical, animal nutrition, and food sectors across over 95 countries. With integrated operations and strong R&D capabilities, Jubilant leverages cost-effective manufacturing and global distribution networks to maintain a competitive edge in the vitamin and active pharmaceutical ingredient markets.
To get more findings about this report Download Market Share
| Report Metric | Details |
|---|---|
| Market Size in 2024 | USD 331.15 Million |
| Market Size in 2025 | USD 338.24 Million |
| Market Size in 2033 | USD 400.67 Million |
| CAGR | 2.14% (2025-2033) |
| Base Year for Estimation | 2024 |
| Historical Data | 2021-2023 |
| Forecast Period | 2025-2033 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Segments Covered | By Source, By Form, By Application, By Distribution Channel, By Region. |
| Geographies Covered | North America, Europe, APAC, Middle East and Africa, LATAM, |
| Countries Covered | U.S., Canada, U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia, |
Explore more data points, trends and opportunities Download Free Sample Report
Anantika Sharma is a research practice lead with 7+ years of experience in the food & beverage and consumer products sectors. She specializes in analyzing market trends, consumer behavior, and product innovation strategies. Anantika's leadership in research ensures actionable insights that enable brands to thrive in competitive markets. Her expertise bridges data analytics with strategic foresight, empowering stakeholders to make informed, growth-oriented decisions.
Speak To AnalystAvailable for purchase with detailed segment data, forecasts, and regional insights.
Get This Report